Luyan Pharma Co.,Ltd.

Shenzhen Stock Exchange 002788.SZ

Luyan Pharma Co.,Ltd. Receivables for the year ending December 31, 2023: USD 799.05 M

Luyan Pharma Co.,Ltd. Receivables is USD 799.05 M for the year ending December 31, 2023, a -5.73% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Luyan Pharma Co.,Ltd. Receivables for the year ending December 31, 2022 was USD 847.65 M, a 5.60% change year over year.
Luyan Pharma Co.,Ltd. Receivables for the year ending December 31, 2021 was USD 802.72 M, a 33.16% change year over year.
Luyan Pharma Co.,Ltd. Receivables for the year ending December 31, 2020 was USD 602.82 M, a 17.51% change year over year.
Luyan Pharma Co.,Ltd. Receivables for the year ending December 31, 2019 was USD 512.97 M, a 25.73% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Shenzhen Stock Exchange: 002788.SZ

Luyan Pharma Co.,Ltd.

CEO	Mr. Jinxiang Wu
IPO Date	Feb. 18, 2016
Location	China
Headquarters	No. 1004, Anling Road
Employees	5,475
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen, China.

Key trends

Past 5 years